Profil
Christina Smolke is the founder of Driver Bioengineering, Inc. Dr. Smolke is also the founder of Antheia, Inc.
Aktive Positionen von Christina Smolke
| Unternehmen | Position | Beginn |
|---|---|---|
Antheia, Inc.
 Antheia, Inc. Pharmaceuticals: OtherHealth Technology Antheia, Inc. provides supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines. The company was founded by Kristy Hawkins, Christina Smolke, Kate Thodey, and Isis Trenchard. The company is headquartered in Menlo Park, CA. | Gründer | - |
Ehemalige bekannte Positionen von Christina Smolke
| Unternehmen | Position | Ende |
|---|---|---|
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Antheia, Inc.
Antheia, Inc. Pharmaceuticals: OtherHealth Technology Antheia, Inc. provides supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines. The company was founded by Kristy Hawkins, Christina Smolke, Kate Thodey, and Isis Trenchard. The company is headquartered in Menlo Park, CA. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
